NIH-funded research U01 cooperative agreement

SEAL Study: Preventing peanut allergy by protecting baby skin

Official title: SEAL (Stopping Atopic dermatitis and ALlergy) Study: Prevent allergy by enhancing the skin barrier

Funded at Harvard University D/b/a Harvard School of Public Health · NIH-11532533 · Data updated 2026-11-12

This trial tests whether using a skin-emollient and proactive skin steroids early in life can prevent peanut allergy in high-risk infants.

More Atopic Dermatitis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionHarvard University D/b/a Harvard School of Public Health
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 1, 2026
Project endMay 31, 2027
Funding year2026
Award (this year)$205,350
NIH project number3U01AI147462-07S2
Project IDNIH-11532533 on NIH RePORTER

Who could benefit from this research

Could help

Infants with early signs of dry skin or eczema within the first 10 weeks of life.

Less likely to help

Infants without early eczema or dry skin who do not fit high-risk criteria may not benefit.

What this research studies

The study enrolls newborns with signs of dry skin or eczema and follows them from early infancy to determine if a proactive skin care approach can lower the chance of developing peanut allergy. Participants are randomized to receive a simple emollient plus proactive topical steroids versus standard reactive care, aiming to reduce eczema severity and duration. The goal is to interrupt the skin-sensitization pathway described in the dual allergen exposure hypothesis, potentially lowering food allergy risk. Parents will receive guidance on skin care, monitor skin symptoms, and report any allergic reactions during the trial.

Why it matters

Potential benefit: If successful, the approach could substantially reduce peanut allergy risk in high-risk infants.

How similar studies have gone: Prior studies have linked early skin barrier health to allergy risk, with emerging evidence suggesting that proactive skin care may reduce sensitization in some populations.

Where this research is happening

  • Harvard University D/b/a Harvard School of Public Health
    Boston, United States
    Active

Researchers

  • Principal investigator: Johnson, Mary — Harvard University D/b/a Harvard School of Public Health
  • Study coordinator: Johnson, Mary

Related research

Other NIH-funded projects on the same topics.

  • Stopping Atopic Dermatitis and Allergy: Preventing Food Allergy by Protecting the Skin

    A large study in infants at high risk for allergies tests whether using a skin barrier cream together with early, proactive skin care can prevent peanut allergy and other food allergies.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11532535

  • SEAL Study: Prevent allergy by protecting the baby’s skin

    A very young group of high-risk babies will try a early skin-care plan to reduce eczema and prevent peanut allergy.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11516452

  • Preventing eczema-related allergies by strengthening infants' skin barrier

    This project will see if using a trilipid skin cream plus proactive mild topical steroids in infants with early dry skin or eczema lowers their chances of developing food allergies.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11418544

  • SEAL: Stopping eczema and allergy by protecting the skin in infants

    A large clinical study in early infancy tests whether using a skin barrier cream together with a gentle anti-inflammatory cream can reduce the chance of developing food allergies.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11406152

  • Preventing food allergies by protecting babies' skin

    This trial tests whether starting a trilipid moisturizer plus early gentle topical steroids for babies with dry skin or early eczema can lower their chance of developing food allergies.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11393205

  • Preventing food allergy by strengthening babies' skin barrier

    See if giving a trilipid emollient plus proactive topical steroid treatment to infants with very early dry skin or eczema can lower their chance of developing food allergies.

    NIH research Harvard University D/b/a Harvard School of Public Health · Boston, United States · NIH-11392091

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.